Aileron Therapeutics, Inc.ALRNNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank8
3Y CAGR-28.0%
5Y CAGR-17.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-28.0%/yr
vs -6.2%/yr prior
5Y CAGR
-17.3%/yr
Recent deceleration
Acceleration
-21.9pp
Decelerating
Percentile
P8
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $63000.00 | - |
| 2024 | $0.00 | -100.0% |
| 2023 | $119000.00 | -29.6% |
| 2022 | $169000.00 | +39.7% |
| 2021 | $121000.00 | -25.8% |
| 2020 | $163000.00 | +5.2% |
| 2019 | $155000.00 | -28.9% |
| 2018 | $218000.00 | +129.5% |
| 2017 | $95000.00 | -59.1% |
| 2016 | $232000.00 | - |